Entero Therapeutics (ENTO) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Entero Therapeutics Appoints Richard Paolone as CEO
Dow JonesFeb 14 16:00 ET
Express News | Entero Therapeutics Appoints Richard Paolone as CEO
ReutersFeb 14 16:00 ET
Entero Therapeutics Secures $2 Million Loan and Appoints New Board Members
Quiver QuantitativeFeb 7 15:30 ET
Express News | Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members
ReutersFeb 7 15:22 ET
Press Release: Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members
Dow JonesFeb 7 15:22 ET
Express News | Entero Therapeutics Inc: Exploring Strategic Alternatives for Purpose of Maximizing Value of All of Our Stakeholders
ReutersNov 27, 2024 17:14 ET

Comments

Jaguar8

Feb 7 14:23

NEWS

$Entero Therapeutics (ENTO.US)$
Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members
Friday, 7th February at 3:22 pm
BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (NASDAQ: ENTO) ("Entero" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has secured a $2 million revolving loan agreement an...

3

Trytosaveabit

Jan 29 15:01

$Entero Therapeutics (ENTO.US)$ 🤔

Jaguar8

Dec 15, 2024 20:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...

28

9

7